**Core Concept**
Pramlintide is a medication used in the management of diabetes mellitus type 1 and type 2. It is a synthetic analogue of amylin, a hormone produced by the pancreas that plays a crucial role in glucose regulation. Amylin helps to slow gastric emptying, suppress postprandial glucagon secretion, and promote satiety.

**Why the Correct Answer is Right**
Pramlintide, being a synthetic amylin analogue, mimics the action of endogenous amylin. It slows gastric emptying by acting on the vagus nerve, thereby reducing postprandial glucose spikes. Additionally, pramlintide suppresses glucagon secretion, which helps to lower blood glucose levels. This dual action makes pramlintide an effective adjunct therapy for diabetes management.

**Why Each Wrong Option is Incorrect**
**Option B:** DPP-4 inhibitors, such as sitagliptin, work by inhibiting the enzyme dipeptidyl peptidase-4 (DPP-4), which breaks down incretin hormones like GLP-1 and GIP. Pramlintide does not inhibit DPP-4, so this option is incorrect.

**Option C:** GLP-1 analogues, such as exenatide, mimic the action of glucagon-like peptide-1 (GLP-1), a hormone that stimulates insulin secretion and inhibits glucagon release. Pramlintide is not a GLP-1 analogue, so this option is incorrect.

**Option D:** PPAR-γ agonists, such as pioglitazone, activate peroxisome proliferator-activated receptor gamma (PPAR-γ), which regulates glucose and lipid metabolism. Pramlintide does not activate PPAR-γ, so this option is incorrect.

**Clinical Pearl / High-Yield Fact**
Pramlintide is administered via subcutaneous injection, typically before meals, to help control postprandial glucose spikes. Its use is particularly beneficial in patients with type 1 diabetes or type 2 diabetes who are using insulin therapy.

**✓ Correct Answer: A. Synthetic amylin analogue**